Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BenRalizumab Effect on Airway Remodeling in Severe Eosinophilic asTHmatics

NCT06288516 is registered in ClinicalTrials.gov with Aristotle University Of Thessaloniki as lead sponsor.

NCT NCT06288516
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06288516 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BenRalizumab Effect on Airway Remodeling in Severe Eosinophilic asTHmatics
Lead sponsor
Aristotle University Of Thessaloniki
Phase
Phase 4
Overall status
Unknown status
Start date
March 1, 2024
Completion date
June 1, 2026
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

airway remodeling, asthma; eosinophilic